New heart valve device offers hope for High-Risk patients
NCT ID NCT07501234
Summary
This early study is testing a new device called the MitraFix system for adults with a severe leaky heart valve who are at high risk for traditional open-heart surgery. The device is delivered through a tube in the leg to try to fix the leaky valve. The main goals are to see if the procedure is safe, if the device can be placed correctly, and if it helps reduce the leak and improve patients' daily life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION (MR) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100037, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.